IP Library Granted Patent US 9,383,331
Granted Patent B2
US 9,383,331 · App. 14/016,889 · Granted Jul 5, 2016

Measurement and uses of oxidative status

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,383,331
App. No.
14/016,889
Granted
Jul 5, 2016
Kind
B2
Abstract

The present invention provides a method of determining the overall oxidative status of a body fluid or a tissue of a patient by measuring the oxidation-reduction potential (ORP) of the body fluid or tissue. The method has been found to be useful in the diagnosis, evaluation and monitoring of patients who have suffered a trauma (such as a head injury), patients suspected of being critically-ill, patients who have a viral infection, and patients suspected of having a myocardial infarction. The method has also been found useful in monitoring and evaluating exercise performance in patients. In addition, the method has been found useful in monitoring and evaluating stored blood products and patients who will receive such a product.

Claims (6)

1. A method of determining when to begin treatment of a patient having a broken bone, the method comprising:

a) at the time of first examination of the patient, measuring the oxidation-reduction potential (ORP) of a body fluid from the patient by contacting the body fluid with an electrode connected to a machine that provides a read out of the ORP; and,

b) comparing the ORP of the body fluid with a normal ORP value;

c) immediately beginning treatment of the patient if the ORP value of the body fluid is statistically greater than the normal ORP value.

2. The method of claim 1 , wherein the treatment is antioxidant therapy.

3. The method of claim 1 wherein the ORP is measured in plasma from the patient.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2021
From: AYTU BIOSCIENCE, INC.
To: CAERUS BIOTECHNOLOGIES
Reel/Frame 057716/0502 →
MERGER Recorded Aug 20, 2015
From: LUOXIS DIAGNOSTICS, INC.
To: ROSEWIND CORPORATION
Reel/Frame 036380/0283 →
CERTIFICATES OF CONVERSION AND INCORPORATION Recorded Aug 20, 2015
From: ROSEWIND CORPORATION
To: AYTU BIOSCIENCE, INC.
Reel/Frame 036400/0479 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 16, 2015
From: BAR-OR, DAVID; BAR-OR, RAPHAEL
To: LUOXIS DIAGNOSTICS, INC.
Reel/Frame 035425/0924 →